Nuvoair Series A Funding Reaches $25M To Expand Patient-Centric Care And Clinical Trials Platform

Jan 19, 2022•over 3 years ago

Amount Raised

$25 Million

Round Type

series a

Boston

Description

NuvoAir, a leading digital healthcare company working in chronic disease management, raised $11M in a latest round of financing. The investment was led by Hikma Pharmaceuticals' venture capital arm, Hikma Ventures, and is an extension of the Series A round, previously announced in June 2021. Additional participation from a new strategic investor and existing investors brings the total Series A round to $25 million.

Company Information

Company

Nuvo Air

Location

Boston, Massachusetts, United States

About

With offices in Boston, MA, and Stockholm, Sweden, NuvoAir is a leading digital health company for chronic disease management and decentralized clinical trials. NuvoAir delivers a more continuous, relationship-based, coordinated and human-centric experience to individuals with complex conditions, with an initial focus on respiratory diseases. NuvoAir partners with health plans and risk-bearing providers with the goal to fully align incentives under a value-based care framework.

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Nuvoair Series A Funding Reaches $25M To Expand Patient-Centric Care And Clinical Trials Platform

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Funding Insights

Company Information